Akizawa T - Search Results

1

RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan.

Mizobuchi M, Ogata H, Onishi Y, Fukuma S, Akizawa T, Fukuhara S. Mizobuchi M, et al. Among authors: akizawa t. Ther Apher Dial. 2017 Aug;21(4):326-333. doi: 10.1111/1744-9987.12540. Ther Apher Dial. 2017. PMID: 28834360

2

Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidism.

Kinugasa E, Akizawa T, Takahashi J, Nabeshima K, Ogata H, Nakayama F, Ideura T. Kinugasa E, et al. Among authors: akizawa t. Nephrol Dial Transplant. 2002;17 Suppl 10:20-7. doi: 10.1093/ndt/17.suppl_10.20. Nephrol Dial Transplant. 2002. PMID: 12386265 Clinical Trial.

3

New strategies for the treatment of secondary hyperparathyroidism.

Akizawa T, Shiizaki K, Hatamura I, Kamimura M, Mizobuchi M, Narukawa N, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S100-3. doi: 10.1053/ajkd.2003.50095. Am J Kidney Dis. 2003. PMID: 12612963 Review.

4

Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ; Worldwide Dialysis Outcomes and Practice Patterns Study. Fukuhara S, et al. Among authors: akizawa t. Kidney Int. 2003 Nov;64(5):1903-10. doi: 10.1046/j.1523-1755.2003.00289.x. Kidney Int. 2003. PMID: 14531826 Free article.

5

Management of secondary hyperparathyroidism of dialysis patients.

Akizawa T, Kamimura M, Mizobuchi M, Shiizaki K, Sumikado S, Sakaguchi T, Negi S, Ogata H, Kinugasa E. Akizawa T, et al. Nephrology (Carlton). 2003 Oct;8 Suppl:S53-7. doi: 10.1046/j.1440-1797.8.s.9.x. Nephrology (Carlton). 2003. PMID: 15012693 Review.

6

Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.

Mizobuchi M, Hatamura I, Ogata H, Saji F, Uda S, Shiizaki K, Sakaguchi T, Negi S, Kinugasa E, Koshikawa S, Akizawa T. Mizobuchi M, et al. Among authors: akizawa t. J Am Soc Nephrol. 2004 Oct;15(10):2579-87. doi: 10.1097/01.ASN.0000141016.20133.33. J Am Soc Nephrol. 2004. PMID: 15466262

7

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M; Japanese Society for Dialysis Therapy. Gejyo F, et al. Among authors: akizawa t. Ther Apher Dial. 2004 Dec;8(6):443-59. doi: 10.1111/j.1774-9987.2004.00199.x. Ther Apher Dial. 2004. PMID: 15663544

8

[Calcium sensing receptor (CaR) agonist].

Mizobuchi M, Akizawa T. Mizobuchi M, et al. Among authors: akizawa t. Nihon Naika Gakkai Zasshi. 2005 May 10;94(5):979-83. doi: 10.2169/naika.94.979. Nihon Naika Gakkai Zasshi. 2005. PMID: 15926471 Review. Japanese. No abstract available.

9

Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD).

Morita S, Fukuhara S, Akizawa T, Asano Y, Kurokawa K. Morita S, et al. Among authors: akizawa t. Clin Exp Nephrol. 2005 Sep;9(3):219-27. doi: 10.1007/s10157-005-0358-7. Clin Exp Nephrol. 2005. PMID: 16189630

10

[Apoptosis: a possible mechanism of suppressing parathyroid hyperplasia by calcimimetics].

Mizobuchi M, Saji F, Shiizaki K, Sato T, Shibata M, Negi S, Akizawa T, Hatamura I, Ogata H, Kinugasa E. Mizobuchi M, et al. Among authors: akizawa t. Clin Calcium. 2005 Sep;15 Suppl 1:56-8; discussion 58-9. Clin Calcium. 2005. PMID: 16272631 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

583 results

Search Page